ANI Pharmaceuticals Inc (NASDAQ:ANIP)
During the Trading Day
| 26.74 |  +1.12 / +4.37% |
Data as of 3:59pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 27.40 | +0.66 / +2.47% |
Volume: 2.1K |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2013 | Quarter 3 2013 | Quarter 4 2013 | Quarter 1 2014 | |||
| Revenue and Income | Net Revenues | 6.2M | 7.8M | 10.5M | 10.9M | |
| Cost of Goods Sold | 7.8M | 4.4M | 2.9M | 2.6M | ||
| Depreciation And Amortization | 146.5K | 381.7K | 437.2K | 703.0K | ||
| Operating Expenses | Gross Income | -1.8M | 3.1M | 7.2M | 7.6M | |
| General Expenses | 2.0M | 2.3M | 3.7M | 4.1M | ||
| Research And Development | 437.2K | 453.9K | 524.5K | 376.0K | ||
| Total Operating Expenses | 9.9M | 7.0M | 7.1M | 7.4M | ||
| Non-Operating Expenses | Operating Income | -3.8M | 810.3K | 3.5M | 3.5M | |
| Extraordinary Charge | 0.00 | -500.7K | -- | 0.00 | ||
| Interest Expense On Debt | 374.5K | -- | 98.00 | 0.00 | ||
| Other Expenses | -434.0K | 648.2K | 31.4K | 29.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -4.6M | 957.9K | 3.5M | 3.5M | |
| Income Taxes | 0.00 | -82.9K | -102.9K | -165.0K | ||
| Preferred Dividend | -2.4M | 0.00 | -801.00 | 0.00 | ||
| Discontinued Operations | 0.00 | 150.3K | 44.7K | 0.00 | ||
| Net Income | -4.6M | 1.2M | 3.4M | 3.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.2M | 9.5M | 9.5M | 10.0M | |
| Shares To Calculate EPS Diluted | 1.2M | 9.5M | 9.5M | 10.0M | ||
| Earnings Per Share | EPS | -$36.12 | $0.13 | $0.36 | $0.33 | |
| EPS Diluted | -$6.02 | $0.13 | $0.36 | $0.33 | ||
.
